|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,011.70 INR | -0.91% |
|
+1.32% | +2.87% |
| 16/05 | Alivus Life Sciences Limited, Q4 2025 Earnings Call, May 16, 2025 | |
| 16/05 | Alivus Life Sciences Limited Provides Earnings Guidance for Fiscal Year 2026 | CI |
| Capitalization | 13TCr 145.97Cr 124.41Cr 116.29Cr 106.99Cr 199.22Cr 224.08Cr 1.39TCr 528.63Cr 5.84TCr 547.45Cr 536.17Cr 21TCr | P/E ratio 2025 |
27.4x | P/E ratio 2026 * | 23.1x |
|---|---|---|---|---|---|
| Enterprise value | 12TCr 142.96Cr 121.84Cr 113.89Cr 104.78Cr 195.11Cr 219.46Cr 1.36TCr 517.72Cr 5.72TCr 536.15Cr 525.1Cr 21TCr | EV / Sales 2025 |
5.52x | EV / Sales 2026 * | 4.8x |
| Free-Float |
23.57% | Yield 2025 |
0.46% | Yield 2026 * | 1.55% |
More valuation ratios
* Estimated data
More news
Last Transcript: Alivus Life Sciences Limited
| 1 day | -0.91% | ||
| 1 week | +1.32% | ||
| Current month | +0.61% | ||
| 1 month | -0.32% | ||
| 3 months | +0.57% | ||
| 6 months | -3.04% | ||
| Current year | +2.87% |
| 1 week | 993.5 |  | 1,051.6 |
| 1 month | 982.4 | | 1,075 |
| Current year | 850 | | 1,251 |
| 1 year | 819.05 | | 1,335.1 |
| 3 years | 370 | | 1,335.1 |
| 5 years | 370 | | 1,335.1 |
| 10 years | 370 | | 1,335.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yasir Rawjee
CEO | Chief Executive Officer | 59 | 13/08/2019 |
| Director of Finance/CFO | - | 01/06/2022 | |
| Compliance Officer | - | 23/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Yasir Rawjee
BRD | Director/Board Member | 59 | 13/08/2019 |
Manju Agarwal
BRD | Director/Board Member | 67 | 30/10/2020 |
| Director/Board Member | 65 | 08/01/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.91% | +1.32% | +14.14% | +114.07% | 145.97Cr | ||
| +1.71% | +0.97% | -14.66% | +137.07% | 69TCr | ||
| +0.41% | -0.14% | +7.03% | -12.67% | 37TCr | ||
| +1.35% | -0.04% | +14.05% | +24.25% | 33TCr | ||
| +0.79% | +1.19% | -54.95% | +11.03% | 31TCr | ||
| -0.53% | -1.92% | +4.92% | -20.57% | 26TCr | ||
| -0.13% | -0.48% | +0.22% | +17.73% | 24TCr | ||
| +0.69% | -1.25% | -14.71% | -6.99% | 22TCr | ||
| +0.51% | -0.66% | -35.39% | -12.41% | 20TCr | ||
| +1.00% | +1.66% | -5.18% | +18.86% | 16TCr | ||
| Average | +0.50% | +1.49% | -8.45% | +27.04% | 27.84TCr | |
| Weighted average by Cap. | +0.83% | +0.90% | -10.65% | +35.86% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 2.41TCr 28Cr 24Cr 22Cr 21Cr 38Cr 43Cr 266.49Cr 101.59Cr 1.12TCr 105.2Cr 103.04Cr 4.09TCr | 2.63TCr 31Cr 26Cr 24Cr 22Cr 42Cr 47Cr 290.86Cr 110.88Cr 1.22TCr 114.82Cr 112.46Cr 4.47TCr |
| Net income | 479.63Cr 5.59Cr 4.77Cr 4.45Cr 4.1Cr 7.63Cr 8.58Cr 53Cr 20Cr 223.65Cr 21Cr 21Cr 815.53Cr | 543.8Cr 6.34Cr 5.4Cr 5.05Cr 4.65Cr 8.65Cr 9.73Cr 60Cr 23Cr 253.57Cr 24Cr 23Cr 924.63Cr |
| Net Debt | -258.4Cr -3.01Cr -2.57Cr -2.4Cr -2.21Cr -4.11Cr -4.62Cr -29Cr -11Cr -120.49Cr -11Cr -11Cr -439.36Cr | 75Cr 87.79L 74.82L 69.94L 64.34L 1.2Cr 1.35Cr 8.34Cr 3.18Cr 35Cr 3.29Cr 3.22Cr 128.03Cr |
More financial data
* Estimated data
Employees
2,014
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/25/08 | 1,011.70 ₹ | -0.91% | 38,127 |
| 07/25/07 | 1,021.00 ₹ | -1.86% | 45,810 |
| 04/25/04 | 1,040.40 ₹ | +0.71% | 83,328 |
| 03/25/03 | 1,033.10 ₹ | +2.14% | 1,44,257 |
| 02/25/02 | 1,011.50 ₹ | +1.30% | 1,13,061 |
Delayed Quote NSE India S.E., July 08, 2025 at 03:31 pm IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,021.00INR
Average target price
1,293.75INR
Spread / Average Target
+26.71%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALIVUS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition